ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today

InPublic |

Amsterdam, The Netherlands - 

Esperite  N.V. (Euronext: ESP,  "Esperite" or "the  Group") announces that today
the  18(th) Tranche  of  EUR  400,000 is  issued  as  a private placement of 40
convertible notes (the "Notes") with a principal amount of EUR 10,000 each, with
497,237 share   subscription  warrants  attached  (the  "Warrants"),  under  the
financing  agreement of up to EUR 13.0 million  signed between the Group and the
European Select Growth Opportunities Fund on  (the "Agreement").
The  Notes  and  the  Warrants  shall  have  the  same  characteristics as those
described in the Group's press release dated .


ESPERITE   group,   listed  at  Euronext  Amsterdam  and  Paris,  is  a  leading
international company in regenerative and precision medicine founded in 2000.
To  learn  more  about  the  ESPERITE  Group,  or  to book an interview with CEO
Frédéric   Amar: +31  575 548 998 - or  visit  the  websites  at and


This  press release  contains inside  information as  referred to  in article 7
paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

With respect to Member States of the European Economic Area that have transposed
European  Directive 2003/71/EC of  the European  Parliament and European Council
(as  amended in particular  by Directive 2010/73/EU to  the extent that the said
Directive  has been transposed  into each Member  State of the European Economic
Area),  no action has been taken or will be taken to permit a public offering of
the  securities referred to in this press release requiring the publication of a
prospectus in any Member State.
This  press  release  and  the  information  it  contains  do not, and will not,
constitute  an offer to subscribe for or  sell, nor the solicitation of an offer
to  subscribe for or buy, securities of Esperite in the United States of America
or  any other jurisdiction. Securities may not  be offered or sold in the United
States  of America absent  registration or an  exemption from registration under
the  U.S. Securities  Act of  1933, as amended  (the "U.S.  Securities Act"), it
being  specified that the securities  of Esperite have not  been and will not be
registered  within the US  Securities Act. Esperite  does not intend to register
securities or conduct a public offering in the United States of America.

PR 18th Tranche:

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Crypto World in Review: Taking in the Good with the Bad

A lot happened in the cryptocurrency industry this week.

Emerging Growth

DirectView Holdings Inc

DirectView Holdings Inc designs and installs surveillance systems, digital video recording and services. The company through its subsidiaries operates within two divisions security and surveillance and video conferencing services.